Your browser is no longer supported. Please, upgrade your browser.
Settings
NSTG [NASD]
NanoString Technologies, Inc.
Index- P/E- EPS (ttm)-2.31 Insider Own0.60% Shs Outstand45.27M Perf Week-3.27%
Market Cap2.60B Forward P/E- EPS next Y-2.19 Insider Trans-55.17% Shs Float44.66M Perf Month13.38%
Income-99.10M PEG- EPS next Q-0.54 Inst Own- Short Float8.57% Perf Quarter-10.13%
Sales133.60M P/S19.46 EPS this Y-139.40% Inst Trans0.04% Short Ratio11.26 Perf Half Y-16.62%
Book/sh4.85 P/B11.89 EPS next Y2.70% ROA-20.70% Target Price77.20 Perf Year29.82%
Cash/sh8.83 P/C6.53 EPS next 5Y- ROE-45.80% 52W Range34.31 - 86.42 Perf YTD-13.74%
Dividend- P/FCF- EPS past 5Y-3.30% ROI-19.90% 52W High-33.24% Beta1.72
Dividend %- Quick Ratio10.10 Sales past 5Y13.40% Gross Margin53.70% 52W Low68.14% ATR2.77
Employees579 Current Ratio10.80 Sales Q/Q50.00% Oper. Margin-66.00% RSI (14)50.25 Volatility5.85% 4.42%
OptionableYes Debt/Eq1.02 EPS Q/Q16.90% Profit Margin-74.10% Rel Volume2.32 Prev Close54.50
ShortableYes LT Debt/Eq1.02 EarningsAug 04 AMC Payout- Avg Volume340.01K Price57.69
Recom1.80 SMA200.92% SMA50-1.18% SMA200-10.60% Volume789,280 Change5.85%
Jan-06-21Upgrade Cowen Market Perform → Outperform $75
Sep-09-20Initiated Morgan Stanley Equal-Weight $43
Nov-15-19Initiated Stifel Buy
Oct-09-18Initiated UBS Buy
Oct-12-17Downgrade Janney Buy → Neutral
Apr-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-11-13Upgrade Robert W. Baird Neutral → Outperform $12 → $18
Sep-09-21 04:00PM  
Sep-01-21 04:00PM  
Aug-31-21 09:02AM  
06:00AM  
Aug-04-21 05:45PM  
04:01PM  
Jul-28-21 03:03PM  
Jul-13-21 01:16PM  
Jul-08-21 06:00AM  
Jun-22-21 06:00AM  
Jun-15-21 06:00AM  
Jun-02-21 05:39AM  
May-27-21 06:00AM  
May-20-21 06:00AM  
May-17-21 06:00AM  
May-10-21 05:15PM  
04:00PM  
May-04-21 03:00AM  
Apr-20-21 09:22AM  
Apr-08-21 06:00AM  
Apr-06-21 06:00AM  
Mar-31-21 06:00AM  
Mar-22-21 10:13AM  
Mar-09-21 06:00AM  
Mar-04-21 02:16AM  
Mar-01-21 05:25PM  
04:56PM  
04:01PM  
10:06AM  
Feb-24-21 06:00AM  
Feb-22-21 06:00AM  
Feb-17-21 06:00AM  
Feb-11-21 06:00AM  
Feb-09-21 06:00AM  
Jan-10-21 03:00PM  
Jan-06-21 12:14PM  
Jan-04-21 04:01PM  
Dec-18-20 08:51AM  
Dec-09-20 06:00AM  
Dec-01-20 06:00AM  
Nov-18-20 04:01PM  
Nov-17-20 06:00AM  
Nov-12-20 04:01PM  
06:47AM  
Nov-11-20 06:00AM  
Nov-09-20 05:25PM  
05:21PM  
04:01PM  
06:00AM  
Nov-06-20 04:01PM  
Nov-02-20 12:31PM  
Oct-13-20 04:01PM  
Oct-08-20 09:33AM  
Oct-07-20 07:58PM  
Oct-06-20 04:18PM  
04:06PM  
Oct-05-20 06:00AM  
Sep-14-20 06:00AM  
Sep-09-20 04:01PM  
09:44AM  
06:00AM  
Sep-03-20 04:01PM  
Aug-11-20 11:00AM  
10:54AM  
Aug-10-20 06:15PM  
04:01PM  
Aug-07-20 08:46AM  
Aug-06-20 06:00AM  
06:00AM  
Aug-05-20 05:49PM  
Aug-03-20 12:31PM  
06:00AM  
Jul-08-20 06:00AM  
Jul-02-20 08:39AM  
Jun-23-20 11:06AM  
Jun-17-20 05:05PM  
Jun-16-20 05:41PM  
May-20-20 09:00AM  
May-19-20 09:37AM  
May-14-20 04:00PM  
May-12-20 06:00AM  
May-11-20 06:00AM  
May-09-20 12:01PM  
May-07-20 06:35PM  
04:01PM  
Apr-15-20 09:00AM  
Apr-07-20 06:34AM  
Apr-06-20 04:01PM  
Mar-27-20 09:47AM  
Mar-07-20 07:05AM  
Mar-05-20 06:00AM  
Mar-04-20 07:21AM  
Mar-03-20 09:41AM  
Mar-02-20 06:05AM  
Feb-28-20 09:44AM  
Feb-26-20 04:00PM  
Feb-20-20 06:00AM  
Feb-19-20 12:31PM  
Feb-18-20 06:00AM  
Feb-10-20 09:00AM  
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malloy KirkDirectorSep 13Option Exercise19.333,00057,9909,510Sep 15 04:35 PM
Malloy KirkDirectorSep 13Sale59.373,000178,1106,510Sep 15 04:35 PM
GRAY R BRADLEYPresident and CEOSep 08Option Exercise6.7212,50084,000169,158Sep 10 04:38 PM
GRAY R BRADLEYPresident and CEOSep 08Sale57.9233,3341,930,804135,824Sep 10 04:38 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentSep 02Sale61.1423,1141,413,20668,270Sep 03 05:13 PM
Bailey K ThomasChief Financial OfficerAug 17Option Exercise11.857,84592,9637,845Aug 19 04:18 PM
Bailey K ThomasChief Financial OfficerAug 17Sale51.987,845407,7760Aug 19 04:18 PM
Malloy KirkDirectorAug 16Option Exercise26.451,50039,6758,010Aug 18 05:09 PM
Malloy KirkDirectorAug 16Sale55.821,50083,7306,510Aug 18 05:09 PM
BROWN J. CHADSVP, Sales & MarketingJul 30Option Exercise17.8211,106197,92011,106Aug 03 04:49 PM
BROWN J. CHADSVP, Sales & MarketingJul 30Sale62.0911,106689,5980Aug 03 04:49 PM
Malloy KirkDirectorJul 13Option Exercise23.341,50035,0108,010Jul 15 04:38 PM
Malloy KirkDirectorJul 13Sale61.161,50091,7406,510Jul 15 04:38 PM
FINNEY ELISHA WDirectorJun 16Sale58.702,760162,0124,650Jun 17 07:04 PM
Malloy KirkDirectorJun 14Option Exercise7.471681,2551,158Jun 15 04:34 PM
Malloy KirkDirectorJun 14Sale60.0516810,088990Jun 15 04:34 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentJun 11Option Exercise6.74142,967963,592223,002Jun 15 04:35 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentJun 11Sale58.94131,8277,770,33991,175Jun 15 04:35 PM
Bailey K ThomasChief Financial OfficerMay 18Option Exercise11.855,22961,9625,229May 20 04:24 PM
Bailey K ThomasChief Financial OfficerMay 18Sale51.105,229267,2170May 20 04:24 PM
GRAY R BRADLEYPresident and CEOMay 12Option Exercise6.7219,940133,997189,743May 14 04:34 PM
GRAY R BRADLEYPresident and CEOMay 12Sale52.9433,3331,764,570156,410May 14 04:34 PM
Malloy KirkDirectorMay 10Option Exercise16.361,50024,5402,490May 12 04:24 PM
Malloy KirkDirectorMay 10Sale63.651,50095,475990May 12 04:24 PM
HERSHBERG ROBERTDirectorApr 15Option Exercise14.711442,1182,034Apr 19 04:17 PM
HERSHBERG ROBERTDirectorApr 15Sale73.9114410,6421,890Apr 19 04:17 PM
BROWN J. CHADSVP, Sales & MarketingMar 25Sale68.784,948340,3230Apr 13 07:51 PM
GRAY R BRADLEYPresident and CEOMar 18Sale65.9621,6841,430,277169,803Apr 13 07:54 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 18Sale65.968,874585,32980,035Apr 13 07:47 PM
Bailey K ThomasChief Financial OfficerMar 17Option Exercise11.8510,458123,91028,613Mar 19 05:14 PM
Bailey K ThomasChief Financial OfficerMar 17Sale65.6328,6131,877,8980Mar 19 05:14 PM
BROWN J. CHADSVP, Sales & MarketingMar 17Sale64.204,754305,2070Mar 19 05:14 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 16Sale66.321,16176,99888,909Apr 13 07:47 PM
Bailey K ThomasChief Financial OfficerMar 16Sale66.321,16176,99818,155Apr 13 07:45 PM
GRAY R BRADLEYPresident and CEOMar 16Sale66.325,179343,471191,487Apr 13 07:54 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 15Option Exercise0.005,376081,554Mar 17 08:15 PM
Bailey K ThomasChief Financial OfficerMar 15Option Exercise0.005,376019,375Mar 17 08:15 PM
GRAY R BRADLEYPresident and CEOMar 15Option Exercise0.0021,9940177,305Mar 17 08:14 PM
BROWN J. CHADSVP, Sales & MarketingMar 15Option Exercise0.005,37605,453Mar 17 08:14 PM
HERSHBERG ROBERTDirectorMar 15Option Exercise11.201,50016,8003,390Mar 17 04:25 PM
HERSHBERG ROBERTDirectorMar 15Sale66.941,500100,4071,890Mar 17 04:25 PM
BROWN J. CHADSVP, Sales & MarketingMar 12Sale64.669,050585,17377Mar 15 04:40 PM
WAITE CHARLES P JRDirectorMar 10Option Exercise7.4710,16875,95512,058Mar 12 04:32 PM
GRAY R BRADLEYPresident and CEOMar 10Option Exercise5.0625,000126,571155,702Mar 12 04:33 PM
GRAY R BRADLEYPresident and CEOMar 10Sale62.0433,3332,068,062122,369Mar 12 04:33 PM
WAITE CHARLES P JRDirectorMar 10Sale62.5010,168635,5001,890Mar 12 04:32 PM
Malloy KirkDirectorMar 08Option Exercise12.802,50032,0103,490Mar 10 04:19 PM
Malloy KirkDirectorMar 08Sale63.142,500157,850990Mar 10 04:19 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 05Option Exercise0.003,741067,698Mar 09 08:54 PM
BROWN J. CHADSVP, Sales & MarketingMar 05Option Exercise0.003,74104,181Mar 09 08:53 PM
GRAY R BRADLEYPresident and CEOMar 05Option Exercise0.0016,4630137,092Mar 09 08:53 PM
Bailey K ThomasChief Financial OfficerMar 05Option Exercise0.004,988015,275Mar 09 08:54 PM
HERSHBERG ROBERTDirectorFeb 16Option Exercise11.201,18813,3063,078Feb 18 04:23 PM
BROWN J. CHADSVP, Sales & MarketingFeb 16Option Exercise17.526,281110,0496,721Feb 18 04:23 PM
BROWN J. CHADSVP, Sales & MarketingFeb 16Sale84.656,281531,687440Feb 18 04:23 PM
HERSHBERG ROBERTDirectorFeb 16Sale80.371,18895,4791,890Feb 18 04:23 PM
BROWN J. CHADSVP, Sales & MarketingJan 28Sale63.188,229519,908440Jan 29 04:17 PM
GRAY R BRADLEYPresident and CEOJan 20Sale72.3425,0001,808,58086,686Jan 22 04:25 PM
HERSHBERG ROBERTDirectorJan 15Option Exercise11.201,50016,8003,390Jan 19 04:15 PM
HERSHBERG ROBERTDirectorJan 15Sale72.621,500108,9231,890Jan 19 04:15 PM
Malloy KirkDirectorJan 11Option Exercise12.802,50032,0103,490Jan 13 04:36 PM
Malloy KirkDirectorJan 11Sale66.532,500166,325990Jan 13 04:36 PM
HERSHBERG ROBERTDirectorDec 15Option Exercise11.201,50016,8003,390Dec 16 04:17 PM
HERSHBERG ROBERTDirectorDec 15Sale69.331,500103,9941,890Dec 16 04:17 PM
Norden GregoryDirectorDec 07Option Exercise1.9210,40619,98012,296Dec 09 04:41 PM
WAITE CHARLES P JRDirectorDec 07Option Exercise18.8837,860714,71139,750Dec 09 04:40 PM
WAITE CHARLES P JRDirectorDec 07Sale60.4737,8602,289,3801,890Dec 09 04:40 PM
Norden GregoryDirectorDec 07Sale58.3210,406606,8921,890Dec 09 04:41 PM
Bailey K ThomasChief Financial OfficerNov 19Option Exercise23.3412,709296,62812,709Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 19Sale47.3512,709601,7290Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 18Option Exercise8.165,93748,4465,937Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 18Sale48.215,937286,1970Nov 20 04:56 PM
HERSHBERG ROBERTDirectorNov 16Option Exercise11.201,50016,8003,390Nov 18 04:17 PM
BROWN J. CHADSVP, Sales & MarketingNov 16Option Exercise17.526,281110,0496,721Nov 18 04:18 PM
BROWN J. CHADSVP, Sales & MarketingNov 16Sale46.216,281290,245440Nov 18 04:18 PM
HERSHBERG ROBERTDirectorNov 16Sale46.671,50070,0021,890Nov 18 04:17 PM
Malloy KirkDirectorNov 09Option Exercise12.802,50032,0103,490Nov 12 05:00 PM
Malloy KirkDirectorNov 09Sale40.962,500102,400990Nov 12 05:00 PM
HERSHBERG ROBERTDirectorOct 15Option Exercise11.201,50016,8003,390Oct 16 04:44 PM
HERSHBERG ROBERTDirectorOct 15Sale39.351,50059,0191,890Oct 16 04:44 PM